European Medical Solutions (ALEMS.BR)

EUR 4.9

(1.07%)

Operating Expenses Summary of European Medical Solutions

  • European Medical Solutions's latest annual operating expenses in 2023 was 13.64 Million EUR , down -19.69% from previous year.
  • European Medical Solutions's latest quarterly operating expenses in 2023 FY was 15.36 Million EUR , down -19.69% from previous quarter.
  • European Medical Solutions reported a annual operating expenses of 19.13 Million EUR in annual operating expenses 2022, up 38.2% from previous year.
  • European Medical Solutions reported a annual operating expenses of 13.84 Million EUR in annual operating expenses 2021, up 1012.1% from previous year.
  • European Medical Solutions reported a quarterly operating expenses of 15.36 Million EUR for 2023 FY, down -19.69% from previous quarter.
  • European Medical Solutions reported a quarterly operating expenses of 7.55 Million EUR for 2023 Q4, down -3.18% from previous quarter.

Annual Operating Expenses Chart of European Medical Solutions (2023 - 2013)

Historical Annual Operating Expenses of European Medical Solutions (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 13.64 Million EUR -19.69%
2022 19.13 Million EUR 38.2%
2021 13.84 Million EUR 1012.1%
2020 1.24 Million EUR -92.69%
2019 17.02 Million EUR 14.31%
2018 14.89 Million EUR 18.27%
2017 12.59 Million EUR -9.83%
2016 13.96 Million EUR 82.7%
2015 7.64 Million EUR 76.64%
2014 4.32 Million EUR 87.28%
2013 2.31 Million EUR 0.0%

Peer Operating Expenses Comparison of European Medical Solutions

Name Operating Expenses Operating Expenses Difference
Nicox S.A. -11.5 Million EUR 218.639%
FERMENTALG 12.34 Million EUR -10.556%
argenx SE 1.34 Billion EUR 98.984%
BioSenic S.A. 7.58 Million EUR -79.968%
Celyad Oncology SA 8.49 Million EUR -60.742%
Hyloris Pharmaceuticals SA 17.98 Million EUR 24.129%
Onward Medical N.V. 20.64 Million EUR 33.897%
Oxurion NV 12.21 Million EUR -11.732%
PHAXIAM Therapeutics S.A. 24.98 Million EUR 45.381%
Financière de Tubize SA 114.38 Thousand EUR -11830.343%
UCB SA 2.94 Billion EUR 99.536%